Cargando…
Exploring the Relationship between Frailty, Functional Status, Polypharmacy, and Quality of Life in Elderly and Middle-Aged Patients with Cardiovascular Diseases: A One-Year Follow-Up Study
The association between frailty, disability in activities of daily living (ADL), polypharmacy, and quality of life (QoL) in middle-aged patients with cardiovascular disease (CVD) is little investigated. This study sought (a) to explore this association comparatively in elderly and middle-aged hospit...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8871852/ https://www.ncbi.nlm.nih.gov/pubmed/35206472 http://dx.doi.org/10.3390/ijerph19042286 |
_version_ | 1784657094809485312 |
---|---|
author | Hiriscau, Elisabeta Ioana Buzdugan, Elena-Cristina Hui, Ligia-Ancuta Bodolea, Constantin |
author_facet | Hiriscau, Elisabeta Ioana Buzdugan, Elena-Cristina Hui, Ligia-Ancuta Bodolea, Constantin |
author_sort | Hiriscau, Elisabeta Ioana |
collection | PubMed |
description | The association between frailty, disability in activities of daily living (ADL), polypharmacy, and quality of life (QoL) in middle-aged patients with cardiovascular disease (CVD) is little investigated. This study sought (a) to explore this association comparatively in elderly and middle-aged hospitalized patients with CVD and (b) to determine which domains of ADL and QoL might improve the frailty prediction. A one-year follow-up study including 90 elderly (≥65 years old) and 89 middle-aged patients (40–65 years old) was conducted. At baseline, frailty assessment was performed based on the Fried criteria; Barthel Index (BI) and Duke Activity Status Index (DASI) were used for ADL, and European Quality of Life-5 dimensions (EQ-5D) for QoL. At follow-up, data were collected via telephone. At baseline, 79 patients (51 elderly and 28 middle-aged) were frail. The CVD frail patients showed functional dependency and a poor QoL compared to the non-frail (p < 0.001) and within each subgroup at follow-up. Mobility was found to predict frailty in both elderly (OR = 2.34) (C.I. (1.03–5.29)) and middle-aged patients (OR = 2.58) (C.I. (1.15–5.78)). The ADL assessment and self-reported QoL may help to identify an aggravation or an advanced frailty condition in hospitalized elderly and middle-aged CVD patients. |
format | Online Article Text |
id | pubmed-8871852 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-88718522022-02-25 Exploring the Relationship between Frailty, Functional Status, Polypharmacy, and Quality of Life in Elderly and Middle-Aged Patients with Cardiovascular Diseases: A One-Year Follow-Up Study Hiriscau, Elisabeta Ioana Buzdugan, Elena-Cristina Hui, Ligia-Ancuta Bodolea, Constantin Int J Environ Res Public Health Article The association between frailty, disability in activities of daily living (ADL), polypharmacy, and quality of life (QoL) in middle-aged patients with cardiovascular disease (CVD) is little investigated. This study sought (a) to explore this association comparatively in elderly and middle-aged hospitalized patients with CVD and (b) to determine which domains of ADL and QoL might improve the frailty prediction. A one-year follow-up study including 90 elderly (≥65 years old) and 89 middle-aged patients (40–65 years old) was conducted. At baseline, frailty assessment was performed based on the Fried criteria; Barthel Index (BI) and Duke Activity Status Index (DASI) were used for ADL, and European Quality of Life-5 dimensions (EQ-5D) for QoL. At follow-up, data were collected via telephone. At baseline, 79 patients (51 elderly and 28 middle-aged) were frail. The CVD frail patients showed functional dependency and a poor QoL compared to the non-frail (p < 0.001) and within each subgroup at follow-up. Mobility was found to predict frailty in both elderly (OR = 2.34) (C.I. (1.03–5.29)) and middle-aged patients (OR = 2.58) (C.I. (1.15–5.78)). The ADL assessment and self-reported QoL may help to identify an aggravation or an advanced frailty condition in hospitalized elderly and middle-aged CVD patients. MDPI 2022-02-17 /pmc/articles/PMC8871852/ /pubmed/35206472 http://dx.doi.org/10.3390/ijerph19042286 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Hiriscau, Elisabeta Ioana Buzdugan, Elena-Cristina Hui, Ligia-Ancuta Bodolea, Constantin Exploring the Relationship between Frailty, Functional Status, Polypharmacy, and Quality of Life in Elderly and Middle-Aged Patients with Cardiovascular Diseases: A One-Year Follow-Up Study |
title | Exploring the Relationship between Frailty, Functional Status, Polypharmacy, and Quality of Life in Elderly and Middle-Aged Patients with Cardiovascular Diseases: A One-Year Follow-Up Study |
title_full | Exploring the Relationship between Frailty, Functional Status, Polypharmacy, and Quality of Life in Elderly and Middle-Aged Patients with Cardiovascular Diseases: A One-Year Follow-Up Study |
title_fullStr | Exploring the Relationship between Frailty, Functional Status, Polypharmacy, and Quality of Life in Elderly and Middle-Aged Patients with Cardiovascular Diseases: A One-Year Follow-Up Study |
title_full_unstemmed | Exploring the Relationship between Frailty, Functional Status, Polypharmacy, and Quality of Life in Elderly and Middle-Aged Patients with Cardiovascular Diseases: A One-Year Follow-Up Study |
title_short | Exploring the Relationship between Frailty, Functional Status, Polypharmacy, and Quality of Life in Elderly and Middle-Aged Patients with Cardiovascular Diseases: A One-Year Follow-Up Study |
title_sort | exploring the relationship between frailty, functional status, polypharmacy, and quality of life in elderly and middle-aged patients with cardiovascular diseases: a one-year follow-up study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8871852/ https://www.ncbi.nlm.nih.gov/pubmed/35206472 http://dx.doi.org/10.3390/ijerph19042286 |
work_keys_str_mv | AT hiriscauelisabetaioana exploringtherelationshipbetweenfrailtyfunctionalstatuspolypharmacyandqualityoflifeinelderlyandmiddleagedpatientswithcardiovasculardiseasesaoneyearfollowupstudy AT buzduganelenacristina exploringtherelationshipbetweenfrailtyfunctionalstatuspolypharmacyandqualityoflifeinelderlyandmiddleagedpatientswithcardiovasculardiseasesaoneyearfollowupstudy AT huiligiaancuta exploringtherelationshipbetweenfrailtyfunctionalstatuspolypharmacyandqualityoflifeinelderlyandmiddleagedpatientswithcardiovasculardiseasesaoneyearfollowupstudy AT bodoleaconstantin exploringtherelationshipbetweenfrailtyfunctionalstatuspolypharmacyandqualityoflifeinelderlyandmiddleagedpatientswithcardiovasculardiseasesaoneyearfollowupstudy |